ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R
出版年份 2018 全文链接
标题
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R
作者
关键词
ADAR3, A-to-I editing, Prognosis, GRIA2<sup>Q607R</sup>, Lower-grade glioma
出版物
Cancer Cell International
Volume 18, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-12-03
DOI
10.1186/s12935-018-0695-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway
- (2018) Long Hai et al. Cell Death & Disease
- Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma
- (2017) Eimile Oakes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dynamic landscape and regulation of RNA editing in mammals
- (2017) Meng How Tan et al. NATURE
- ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion
- (2017) Valeriana Cesarini et al. NUCLEIC ACIDS RESEARCH
- Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas
- (2017) Zheng Zhao et al. Scientific Data
- R/G editing in GluA2Rflop modulates the functional difference between GluA1 flip and flop variants in GluA1/2R heteromeric channels
- (2017) Wei Wen et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- RNA Editing: A Contributor to Neuronal Dynamics in the Mammalian Brain
- (2016) Mikaela Behm et al. TRENDS IN GENETICS
- CDKN2ALoss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II–III) Astrocytomas
- (2015) Gerald F. Reis et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- A-to-I editing of coding and non-coding RNAs by ADARs
- (2015) Kazuko Nishikura NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas
- (2015) Ming-Yang Li et al. PLoS One
- Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma
- (2015) Sara Tomaselli et al. GENOME BIOLOGY
- RNA-seq of 272 gliomas revealed a novel, recurrentPTPRZ1-METfusion transcript in secondary glioblastomas
- (2014) Zhao-Shi Bao et al. GENOME RESEARCH
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Adenosine-to-inosine RNA editing and human disease
- (2013) William Slotkin et al. Genome Medicine
- Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells
- (2012) Yukti Choudhury et al. JOURNAL OF CLINICAL INVESTIGATION
- ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis
- (2012) F Galeano et al. ONCOGENE
- Functions and Regulation of RNA Editing by ADAR Deaminases
- (2010) Kazuko Nishikura Annual Review of Biochemistry
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling
- (2008) Jochen C Hartner et al. NATURE IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started